Research establishes ERβ as a tumor suppressor in inflammatory breast cancer

FHS
July 4, 2023
3:07 am

A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “ERβ as a mediator of estrogen signaling in inflammatory breast cancer.”

Elation Health Unveils Unified EHR and Billing Solution for Primary Care

What You Should Know: Elation Health, the clinical-first technology company powering innovation in primary care, today announced general availability of the industry’s first unified EHR

October 4, 2023

AbbVie dramatically outspent its pharma company rivals in 2023 to promote its drugs to doctors

WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to promote its drugs, according to a STAT analysis of newly

July 5, 2024

Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors

SAN ANTONIO — Women ages >50 who de-escalated to less-frequent mammography 3 years after curative surgery for early-stage breast cancer had similar outcomes to women

December 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.